ARRANGEMENT FOR AND METHOD OF ADMINISTERING A PHARMACEUTICAL PREPARATION

BACKGROUND OF THE INVENTION

1. Field of the Invention

This invention generally relates to an arrange¬ ment for, and a method of, administering a pharmaceutical preparation and, more particularly, to the administration of an orally active pharmaceutical preparation contained in non-tacky coated pellets by breaking open a frangible packet containing the pellets, and by pouring the pellets from the opened packet into a human or animal patient's mouth.

2. Description of Related Art

Pharmaceutical preparations are traditionally orally administered to patients in many forms.- Tablets are often used, but are not altogether desirable in certain cases. For example, depending on their size and coating, tablets can be difficult for certain pat¬ ients, particularly children or small animals, to swallow. In some instances, the tablets begin to dissolve immed¬ iately upon coming into contact with saliva iri the mouth, causing the unpleasant taste of the medicinal preparation to be sensed. In addition, relatively small tablets can be easily concealed or stolen. This

SUB _S TITUTE SHEET

is a particular importance in the administration of methadone and like drugs to narcotic addicts, or other medications to mental patients, because such patients may sometimes not swallow the tablets, but, instead, conceal them in their mouths or clothing in order to sell or dispose of the medication.

Capsules are also commonly used, particularly in those cases where slow or sustained release of the pharmaceutical preparation is desired. Although gener¬ ally satisfactory for their intended purpose, capsules which enclose the pharmaceutical preparation within a gelatin container are generally larger in size than tablets and, hence, aggravate the swallowing problem. To overcome this problem, some patients break open the capsules to swallow the pharmaceutical preparation within the gelatin container, but often the pharmaceutical prep¬ aration has a bitter taste. In any event, the breaking open of a gelatin container can be messy and cause loss of part of the dosage amount.

Liquid pharmaceutical formulations are also generally satisfactory, but often need to be refriger¬ ated or shaken prior to use. In some instances, such as certain pediatric antibiotic suspensions, prepara¬ tion of the liquid formulations require addition of water to a powder immediately prior to use. Unless measuring spoons or the like are used, the dosing of

SUBSTITUTE SHEET

- 3 -

the liquid formulation may be inaccurate, and spillage is a frequent problem, particularly with children. Also, liquid formulations often contain sweeteners, coloring and flavoring agents and other additives , many of which are not acceptable to nutrition-minded patients. Liquid formulations are also not stable for lengthy periods.

Another common problem with pharmaceutical preparations in tablet or capsule form is that there is very little room, if any, to print indicia on the tablet or capsule itself. Such indicia could be very useful if they identified the preparation itself, the dosage amount, the expiration date, or provided warning notices or directions for use. To meet this need, some drug manufacturers will design a tablet with a characteristic shape or color, or imprint an identifying mark on the tablet. However, no room exists on the tablet itself for more printed information and, generally, this in¬ formation would be provided on a bottle or other rela¬ tively large-sized container housing the individual tablets or capsules.

However, such large-sized bottles or contain- ers are generally too large to fit in one's pocket and, rather than being carried about, are generally stored in one's medicine cabinet and thus are out of sight of the patient when the tablet/capsule is being orally

SUBSTITUTE SHEET

taken. In the case where a patient takes multiple medications, the medications are often co-mingled in a pill box or similar unmarked container, whereby the medications can be identified, if at all, only by their size, shape and color and reference to a pharma¬ ceutical text. Elderly patients, especially, may be¬ come confused when unmarked medications are present in an unmarked holder, and may possibly take the wrong medication at the wrong time or exceed their recommended dosage of a given medication.

SUMMARY OF THE INVENTION

1. Objects of the Invention

It is a general object of this invention to provide a novel arrangement for administering pharma¬ ceutical preparations which avoids the aforementioned drawbacks inherent in tablet, capsule or liquid formu¬ lations.

It is another object of this invention to pro¬ vide an easily-openable packet containing the pharma¬ ceutical preparation for prompt dispensing of the prep¬ aration.

A further object of this invention is to pro¬ vide a miniaturized, frangible packet small enough -to be easily carried in one's pocket and large enough to bear indicia identifying, e.g., the pharmaceutical

SUBSTITUTE SHEET

5 -

.preparation, the dosage, the expiration date, warning notices, and use instructions.

Yet another object of this invention is to provide pharmaceutical preparations in the form of coated pellets which are easy to swallow or to combine with liquids or foods for oral ingestion.

Still another object of this invention is to provide the coated pellets with non-tacky coatings to prevent the pellets from adhering to one another or to their container during manufacturing, storage and/or use,

A still further object of this invention is to orally administer the pellets while concealing the taste of the pharmaceutical preparation contained therein.

Another object of this invention is to sub¬ stantially prevent the pellets from dissolving immedi¬ ately upon entry into a patient's mouth, yet provide for easy dissolution in the stomach for quick absorp¬ tion into the bloodstream.

Yet another object of this invention is to administer the pharmaceutical preparation to persons of all ages, e.g., pediatric or geriatric patients, and to animals.

An additional object of this invention is to provide a novel form for pharmaceutical preparations administered to drug addicts and psychiatric patients

SUBSTITUTE SHEET

which will substantially prevent theft or concealment of the medications.

Still another object of this invention is to provide a normally-sealed packet which, once its seal is broken, cannot be re-sealed, thereby preventing tampering with the medication.

Another object of this invention is to pro¬ vide a readily disposable pellet-containing packet.

A further object of this invention is to pro¬ vide a novel method of administration of a pharmaceuti¬ cal preparation which is easy to swallow, inexpensive to manufacture, and convenient to use.

2. Features of the Invention In keeping with these objects, and others which will become apparent hereinafter, one feature of this invention resides, briefly stated, in an arrange¬ ment for, and a method of, administering one or more dosage units of a pharmaceutical preparation which com¬ prises a multitude of pellets containing the pharma¬ ceutical preparation contained in a breakable packet. The breakable packet includes a backing sheet, prefer- ably constituted of a paper material, and a covering member, preferably constituted of a synthetic plastic material and overlying the backing sheet. The covering member and backing sheet together bound, a compartment

SUBSTITUTE SHEET

_ 7 _

in which the pellets are contained. The pellets have non-tacky coatings to prevent them from adhering to one ^' another and to the packet. The packet has a frangi¬ ble zone which, when broken, enables removal of the pel¬ lets from the compartment.

In use, the backing sheet is bendable when subjected to external forces, e.g., moderate fingertip pressures, at the frangible zone. When the backing sheet is bent, the covering member fractures at the frangible zone into fractured parts whereby an opening in the compartment is created, permitting removal of the pel¬ lets. The fractured parts remain on the bent backing sheet for ease of disposal.

Preferably, the covering member includes a hollow main portion having a predetermined cross-sec¬ tion, a neck portion having a cross-section less than said predetermined cross-section, and a flange portion sealed and attached to one major surface of the backing sheet. In the preferred embodiment, the frangible zone extends across the neck portion and ^' , when the covering member fractures at the neck portion, walls are formed at the neck portion which bound a tapered pouring spout or funnel through which the pellets pass.

An opposite major surface of the backing sheet is advantageously applied with indicia to identify the pharmaceutical preparation itself, the dosage amount,

SUBSTITUTE SHEET

the expiration date, and can provide warning notices or use instructions, as desired.

The covering member is preferably constituted of a light-transmissive material to permit viewing of the pellets through the covering member. In this way, a user can verify the extent to which the pellets have been removed from the packet.

Another feature of this invention resides in providing a non-tacky coating for each medication-con¬ taining pellet, said coating comprising a polymeric material, e.g., a cationic copolymeric acrylate resin based on methacrylate and neutral methacrylic acid esters. The coating further includes a basic compound filler that is soluble in acid. Any organic or inor¬ ganic compound having a high solubility; rate in an acidic medium such as gastric juices may serve as the basic compound filler. As preferred embodiments, the filler may be calcium carbonate, aluminum hydroxide or magnesium carbonate, or any mixture thereof.

In use, the pellet coating surrounding the pharm¬ aceutical preparation prevents the latter from being dissolved upon contact with saliva in a patient's mouth and, instead, delays such dissolution until the pellets reach the gastric juices in the patient's stomach. The basic compound dissolves in the acidic gastric juices and liberates the pharmaceutical preparation.

SUBSTITUTE SHEET

9 -

Thus, the basic compound filler may be usedin an amount sufficient to facilitate the desired release charac¬ teristics of the preparation. Typically, the filler is present in the coating in an amount from about 10% to about 90% by weight.

The polymeric material is advantageously selected from the group consisting of cellulosic, poly- acrylate and polyvinyl alcoholic polymers.

A single packet may contain one or more com¬ partments, each containing a fraction of a recommended dose to be administered to, a patient. Likewise, multi¬ ple packets representing multiple doses can be provided on a common backing sheet or on a roll, and can be detached from the roll as required in order to allow precise dosages to be administered to the patient.

The average size of each pellet is generally not greater than 1 mm in diameter.

The novel features which are considered as characteristic of the invention are set forth in ^* parti¬ cular in the appended claims. The invention itself, however, both as to its construction and its method of operation, together with additional objects and advan¬ tages thereof, best will be understood from the follow¬ ing description of specific embodiments when read in connection with the accompanying drawings.

SUBSTITUTE SHEET

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a front perspective view of an arrangement for administering a pharmaceutical prep¬ aration in accordance with this invention;

FIG. 2 is an enlarged cross-sectional view taken on line 2—2 of FIG. 1;

FIG. 3 is a greatly enlarged sectional view of one of the multitude of pelle ^' ts containing the pharmaceutical preparation;

FIG. 4 is a rear view of the arrangement of FIG. 1, bearing printed indicia; and

FIG. 5 is a top plan view of another arrange¬ ment for administering a pharmaceutical preparation in accordance with, this invention.

SUBSTITUTE SHEET

- 11 -

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

Referring now to FIGs. 1 and 2, reference numeral 10 generally identifies an arrangement for administering a pharmaceutical preparation. The ar¬ rangement 10 comprises a multitude of pellets, a rep¬ resentative one 12 of which is shown in enlarged sec¬ tional view in FIG. 3. The pellets 12 contain the pharmaceutical preparation to be administered to a patient.

The arrangement 10 further comprises a break¬ able packet 14 for holding the pellets 12. The packet includes a backing sheet 16, preferably constituted of a paper material, although vinyl and other thin, flex¬ ible sheeting materials may be utilized. The backing sheet generally, although not necessarily, lies in a plane and has opposite major surfaces, namely, top surface 18 and bottom surface 20. The paper material of the backing sheet renders the same bendable, and provides a certain degree of frangibility.

The packet 14 further includes a covering member 22 , preferably constituted of a synthetic plas¬ tic material which is light-transmissive. The covering member 22 includes a hollow main portion 24 having a predetermined half-cylindrical cross-section, a neck portion 26 having a half-frusto-conical cross-section less than said cross-section of main portion 24, a

SUBSTITUTE SHEET

head portion 28 having a half-spherical cross-section, and a generally planar flange portion 30 extending in a plane outwardly of the main, neck and head portions and sealed to said top surface 18 of the backing sheet 16, preferably by means of a vacuum seal formed by heat and pressure. The main, neck and head portions extend outwardly of top surface 18, and bound therewith a com¬ partment 32 in which the pellets 12 are contained with clearance.

The packet 34 is provided with a frangible zone 34 which, when broken, enables removal of the pel¬ lets 12 from the compartment 12. In a preferred embodi¬ ment, the frangible zone 34 extends across the neck por¬ tion 26 at the juncture between the neck and head por¬ tions, i.e., where the covering member has its smallest cross-section.

As previously mentioned, the backing sheet has a certain degree of frangibility and is bendable when subjected to external forces at the neck portion. The covering member has a degree of rigidity and, hence, frangibility greater than that of the backing sheet so that the covering member fractures at the neck portion when external forces, e.g., fingertip pressure, bend the backing sheet. Indeed, in use, the synthetic plas¬ tic material of the covering member does not substan¬ tially exhibit plastic deformation, but, instead,

SUBSTITUTE SHEET

13 -

cracks open, whereas, the paper backing sheet merely creases. The covering member actually cracks into two fractured parts, both of which remain attached to the bent backing sheet due to the presence of the flange portion 30. Once cracked open, the frusto- conically-shaped neck portion has tapered walls bound¬ ing a pouring spout through which the pellets may pass for administration of the pharmaceutical preparation. The light-transmissive covering member permits the patient to view the pellets through the covering mem¬ ber to evaluate how many of the pellets have been re¬ moved from the compartment.

The juncture between the neck 26 and the head 28 portions of the covering member is sufficient, due to its reduced cross-section, to constitute the frangible zone at which the covering member is frac¬ tured. In some cases, it may be desirable to facili¬ tate the breaking, operation by further weakening the frangible zone by providing a crease line across the rear of the backing sheet 16 immediately behind the aforementioned juncture. As shown in FIG. 4, the crease line can also be constituted by a series of linear perforations 36, none of which goes entirely through the backing sheet in order to maintain the integrity and seal of the compartment 32.

SUBSTITUTE SHEET

Also shown in FIG. 4 is a set of exemplary indicia applied, e.g. , by printing, onto the bottom surface 20 of the backing sheet 16. The indicia may include the identification of the drug, instructions as to how to break open the packet, the dosage amount of the pharmaceutical preparation within the packet, directions for use, the expiration date, a warning notice, and any other information which the drug manu¬ facturer wishes to impart to the patient. The indicia need not be applied only to the bottom surface 20 of the backing sheet; they could equally as well be ap¬ plied to the front surface thereof, or to the covering member.

As shown in FIG. 5, more than one breakable packet can be attached to the same backing sheet. Thus, packets 14, 14A are both provided on a backing sheet 38 in an analogous manner to that described earlier for backing sheet 16, except that the backing sheet 38 is provided with a V-shaped notch 40 to permit ready detachment of each packet from the backing sheet 38 by tearing along the notch 40. Alternatively, each of the packets 14, 14A may be separately opened for removal of the pellets by rupturing the juncture be¬ tween the neck 26 and head 28 on each packet when de¬ sired, without separation of the backing sheets of the joined packets.

This invention also contemplates the provi¬ sion of more than two packets on a single backing sheet 38 and, indeed, the packets can be mounted on a continuous strip wound in a roll, or on a large sheet, each packet being detachable from the strip by any con¬ venient tear-off means, or being separately rupturable for removal of the pelletized medication.

Turning, then, to FIG. 3, each pellet con¬ tains a core 42 of a pharmaceutical preparation com¬ prising one or more active ingredients, and pharma¬ ceutically acceptable excipients, binders and fillers, if any, as well as a non-tacky outer coating 44. Each peller has an average total diameter of not greater than 1 mm. Each non-tacky coating includes a polymeric material, which advantageously comprises a polymer which is a cationic copolymeric acrylic resin based on metha- crylate and neutral methacrylic acid esters, and a basic compound filler. An example of such cationic copolymeric acrylic resin is "EUDRAGIT E" (Phar a International) .

As a basic compound, any organic or inorganic compound having a high degree of solubility in an

» acidic medium may be used and, as preferred embodi¬ ments, calcium carbonate, aluminum hydroxide or mag¬ nesium carbonate may be mentioned. The filler is pref¬ erably present in an amount from about 10% to about 90%

by weight of the coating, preferably in a range from about 30% to about 60% by weight and, still more pref¬ erably, in amount about 50% by weight. The filler reduces the amount of polymer that is used, greatly reducing manufacturing costs. The filler reduces the tackiness of the polymer to not only reduce manufac¬ turing difficulties in coating, but also promotes the dissolution of the pellets in the gastric juices of a patient's stomach, as heretofore described.

A major purpose of the coating is also to mas the taste of the pharmaceutical preparation in the cores of the pellets and, accordingly, to delay the dissolution of the pellets until they have reached the patient's stomach.

Another embodiment of this invention involves utilizing as the polymeric material in the pellet coat¬ ing a water-soluble polymer such as gelatin or hydrogel compounds. Examples of such water-soluble polymers are acryiamide, N-vinyl pyrolidone and N,N'-methylenebis- acrylam±de.

The pharmaceutical preparation itself can com¬ prise any orally-active, gut-absorbably active ingredi¬ ent including, by way of example,

SUBSTITUTE SHEET

- 16A -

analgesics, such as acetaminophen, aspirin, ibuprofen, morphine; antiasthmatics, such as theophylline, albuterol, prednisone, prednisolone; antimicrobials (antibacterials, antibiotics, antifungal agents), such as sulfa drugs, trimethoprim, nitrofurantoin, penicillins, cephalosporins, tetracyclines, chloramphenicol, erythromycin, griscofulvin, nystatin; antihistamines, such as phenylpropranola ine, pseudoephedrine ■ clemastine, terfenadine; anti-inflam¬ matory agents, such as phenylbutazones, salicylates, steroids, naproxen, piroxicam, indomethacin, ketoprofen, sulindac; antiepileptic agents, such as valproic acid, carbamazepine; cough and cold medicines, such as dextro- ethorphen, guaifenesin, chlorphenitamine, ammonium chloride; cardiovascular agents, such as labetolol-, propranolol, timolol, verapamil, diltiazem, nifedipine, procainamide guinidines; diuretics, such as furosemide, thiazides, spironolactone; laxatives, such as doσusate, bisacodyl; tranquilizers, such as lorazepam, prazepam, diazepam, chlordiazepoxide, hydroxyzine, meprobamate, phenothiazines; vitamins.

The backing sheet need not be constituted solely of paper, but may be coated with a plastic or aluminum layer.

s DESTITUTE SHEEi

- 17 -

In practice, the novel pharmaceutical dis¬ pensing arrangement is provided to a health profes¬ sional or to the patient who administers the pharma¬ ceutical preparation by rupturing one or more of the individual dosage packets and pouring the contents into the mouth of the patient for immediate swallowing, with or without water or other accompanying liquid. The pellets would normally be self-administered into the mouth, except in the case of small children, elderly or incapacitated patients, or drug addicts, psychiatric patients and otherswho .may conceal or not take their medication if self-administration is permitted.

- 18

It will be understood that each of the ele¬ ments described above, or two or more together, also may find a useful application in other types of con¬ structions differing from the types described above.

While the invention has been illustrated and described as embodied in an arrangement for, and method of, administering a pharmaceutical preparation, it is not intended to be limited to the details shown, since various modifications and structural changes may be made without departing in any way from the spirit of the present invention.

Without further analysis, the foregoing will so fully reveal the gist of the present invention -that others can, by applying current knowledge, readily adapt it for various applications without omitting features that, from the standpoint of prior art, fairly consti¬ tute essential characteristics of the generic or speci¬ fic aspects of this invention and, therefore, such adap¬ tations should and are intended to be comprehended within the meaning and range of equivalence of the fol¬ lowing claims.

What is claimed as new and desired to be pro- tected by Letters Patent is set -forth in the appended claims.

SUBSTITUTE SHEET